A detailed history of Smithfield Trust CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Smithfield Trust CO holds 343 shares of CRL stock, worth $69,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares
343
Previous 330 3.94%
Holding current value
$69,087
Previous $79,000 16.46%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $2,645 - $3,554
13 Added 3.94%
343 $92,000
Q3 2023

Nov 06, 2023

BUY
$194.44 - $217.61 $18,471 - $20,672
95 Added 40.43%
330 $65,000
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $21,067 - $27,174
120 Added 104.35%
235 $53,000
Q1 2020

May 05, 2020

BUY
$98.9 - $178.34 $4,450 - $8,025
45 Added 64.29%
115 $15,000
Q4 2017

Feb 02, 2018

BUY
$100.43 - $118.09 $7,030 - $8,266
70
70 $8,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.